About this trial
The purpose of this study is to explore the optimal treatment strategy for retained products of pregnancy. Compared with surgical treatment, prospectively observe whether drug-assisted expectant management until the right time for surgery reduce the occurrence of intrauterine adhesions, and thus protect fertility.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Uterine curettage
- Expectant care
Treatment groups
Sponsors and collaborators
The Third Xiangya Hospital of Central South University
Lead sponsor
Changsha Hospital for Maternal and Child Health Care
Collaborator
ZhuZhou Central Hospital
Collaborator
Xiangtan Central Hospital
Collaborator
Xiangtan Hospital for Maternal and Child Health Care
Collaborator
Yiyang Hospital for Maternal and Child Health Care
Collaborator
The First People's Hospital of YueYang
Collaborator
The First People's Hospital of Changde City
Collaborator
The First Affiliated Hospital of Shaoyang University
Collaborator
Hunan University of Medicine General Hospital
Collaborator
Hengyang Central Hospital
Collaborator
Chenzhou Hospital for Maternal and Child Health Care
Collaborator
Yongzhou Center Hospital
Collaborator
Hunan Provincial People's Hospital
Collaborator
Changsha Maternal and Child Health Hospital
Collaborator
Liuyang People's Hospital
Collaborator